AU6594000A - Remedies for myocardial infarction - Google Patents

Remedies for myocardial infarction

Info

Publication number
AU6594000A
AU6594000A AU65940/00A AU6594000A AU6594000A AU 6594000 A AU6594000 A AU 6594000A AU 65940/00 A AU65940/00 A AU 65940/00A AU 6594000 A AU6594000 A AU 6594000A AU 6594000 A AU6594000 A AU 6594000A
Authority
AU
Australia
Prior art keywords
remedies
myocardial infarction
infarction
myocardial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65940/00A
Inventor
Masafumi Kitakaze
Hiroshi Murata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU6594000A publication Critical patent/AU6594000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65940/00A 1999-08-17 2000-08-17 Remedies for myocardial infarction Abandoned AU6594000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23088999 1999-08-17
JP11/230889 1999-08-17
PCT/JP2000/005504 WO2001012198A1 (en) 1999-08-17 2000-08-17 Remedies for myocardial infarction

Publications (1)

Publication Number Publication Date
AU6594000A true AU6594000A (en) 2001-03-13

Family

ID=16914902

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65940/00A Abandoned AU6594000A (en) 1999-08-17 2000-08-17 Remedies for myocardial infarction

Country Status (3)

Country Link
JP (1) JP3845307B2 (en)
AU (1) AU6594000A (en)
WO (1) WO2001012198A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0676399T3 (en) * 1992-12-25 2000-03-20 Chugai Pharmaceutical Co Ltd Methotrexate derivatives
CA2216647A1 (en) * 1995-03-27 1996-10-03 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical agents containing methotrexate derivatives
AU1942497A (en) * 1996-03-19 1997-10-10 Chugai Seiyaku Kabushiki Kaisha Uveitis remedy

Also Published As

Publication number Publication date
WO2001012198A1 (en) 2001-02-22
JP3845307B2 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
AU5546000A (en) Compounds
AU1278701A (en) Novel compounds
AU4318000A (en) Agarobiose-containing composition
AU3837300A (en) Remedies
AU1290501A (en) Composition
AU2408300A (en) Novel compounds
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU2642699A (en) Remedies for brain infarction
AU6642900A (en) Improved materials for mycoculture
AU4132200A (en) Novel compounds
AU6310600A (en) Composition
AU2109700A (en) Novel compounds
AU5787901A (en) Compound
AU6594000A (en) Remedies for myocardial infarction
AU5567600A (en) Hairdye composition
AU2461200A (en) Remedies
AU5119400A (en) Compounds
AU6610500A (en) Antidiscoloration composition
AU2288900A (en) Novel compounds
AU6168900A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU1539901A (en) Composition
AUPQ346999A0 (en) Substituted diboron compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase